May 20, 2020
Astellas Pharma President and CEO Kenji Yasukawa expressed his confidence on May 18 that the company will be able to achieve the goals of its ongoing three-year business plan through March 2021 thanks to Xtandi’s (enzalutamide) ongoing momentum and full...read more